We are live on ! Find out more
IMI

Intermolecular, Inc.
IMI

Delisted

IMI was delisted on the 19th of September, 2019.

27 hedge funds and large institutions have $18.3M invested in Intermolecular, Inc. in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 4

4% less funds holding

Funds holding: 2827 (-1)

6% less capital invested

Capital invested by funds: $19.5M → $18.3M (-$1.26M)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

Holders
27
Holders Change
-1
Holders Change %
-3.57%
% of All Funds
0.67%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
9
Reduced
4
Closed
4
Calls
Puts
Net Calls
Net Calls Change

IMI Hedge Fund Activity: Q4 2016 in Review

27 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Intermolecular, Inc. (IMI) for Q4 2016, worth a combined $18.3M — down 6.5% from $19.5M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of IMI and 3 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 9 added.

The largest buyer was Raging Capital Management, adding an estimated $1.19M. The largest seller was Cowen Prime Advisors, cutting an estimated $1.28M.

  • 27 institutional investors held Intermolecular, Inc. (IMI) as of Q4 2016, down from 28 in Q3 2016.
  • Funds reported $18.3M of Intermolecular, Inc. stock for Q4 2016, down 6.5% quarter-over-quarter.
  • 3 funds opened new Intermolecular, Inc. positions in Q4 2016 and 4 closed out, a net change of -1 holder.
  • The largest Intermolecular, Inc. buyer in Q4 2016 was Raging Capital Management, an estimated $1.19M added.
  • The largest Intermolecular, Inc. seller in Q4 2016 was Cowen Prime Advisors, an estimated $1.28M sold.

Based on aggregated 13F filings for Q4 2016.